United States Dermatology Devices Market to Reach USD 26.01 Billion by 2030 | CAGR 9.8% (2025-2030) | Driven by Aesthetic Treatments & Skin Disorders | North America leads (40%) | Key Players - AbbVie (Allergan), Alma Lasers, Galderma, Cutera

Leander, Texas and Tokyo, Japan - Feb.5.2026
The dermatology devices market was valued at USD 15.9 billion in 2025 and is on track to reach USD 26.01 billion by 2030, advancing at a 9.8% CAGR.

The market is driven by rising prevalence of skin disorders and growing demand for aesthetic treatments. Devices such as lasers, light-based systems, and diagnostic imaging tools dominate adoption. Hospitals, dermatology clinics, and cosmetic centers are primary end-users. Technological advancements, increasing awareness of skin health, and growth in minimally invasive cosmetic procedures fuel market growth.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/dermatology-devices-market?praveen

Dermatology Devices Market: Competitive Intelligence
AbbVie (Allergan), Alma Lasers, Bruker, Galderma, Cutera, and Hologic (Cynosure)

The Dermatology Devices Market is expanding rapidly as demand grows for minimally invasive aesthetic treatments, advanced skin diagnostics, and effective therapeutic solutions for dermatological conditions. Companies such as AbbVie (Allergan), Alma Lasers, Bruker, Galderma, Cutera, and Hologic (Cynosure) are shaping the market by offering a wide portfolio of laser systems, energy-based devices, imaging and diagnostic tools, and combination therapy platforms. These technologies support applications across medical dermatology, cosmetic procedures, skin resurfacing, body contouring, acne treatment, and pigmentation disorders, catering to both clinical and aesthetic care settings.

The competitive strength of the Dermatology Devices Market lies in the integration of clinical expertise, technological innovation, and strong brand ecosystems. AbbVie (Allergan) and Galderma leverage deep dermatology and aesthetics portfolios, often combining devices with injectables and topical therapies to deliver comprehensive treatment solutions. Alma Lasers, Cutera, and Cynosure (Hologic) focus on advanced laser, radiofrequency, and ultrasound technologies that emphasize precision, safety, and customizable treatment outcomes. Bruker contributes high-resolution imaging and analytical systems that enhance skin assessment, research, and diagnostic accuracy. Together, these companies drive continuous innovation, expand treatment accessibility, and position dermatology devices as a core component of modern skin health and aesthetic medicine.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/dermatology-devices-market?praveen

Fund Raisings
✅ January 2026 - Candela Medical (United States)
Candela Medical secured strategic investment to expand its dermatology and aesthetic device portfolio, including laser and energy-based systems. The funding supports innovation in skin resurfacing, vascular lesion treatment, and hair removal technologies.

✅ December 2025 - Cutera, Inc. (United States)
Cutera raised growth capital to strengthen its non-invasive dermatology and aesthetic treatment platforms. The investment focuses on advanced laser systems, body contouring devices, and improved treatment precision.

✅ November 2025 - Lumenis (Israel)
Lumenis attracted fresh investment to advance its energy-based dermatology devices for skin rejuvenation and medical aesthetics. The funding supports R&D in minimally invasive technologies and global market expansion.

✅ October 2025 - Alma Lasers (Sisram Medical) (Israel)
Alma Lasers secured capital to expand its dermatology device offerings, including radiofrequency and ultrasound-based systems. The investment emphasizes multi-platform devices, treatment customization, and clinical efficacy.

✅ September 2025 - Solta Medical (United States)
Solta Medical raised funding to enhance its dermatology and aesthetic device solutions. The investment focuses on next-generation RF microneedling, skin tightening technologies, and practitioner-friendly systems.

Product Launches & Strategic Partnerships
✅ January 2026 - Candela Medical (United States / Global)
Candela Medical launched an advanced energy-based dermatology device designed for skin rejuvenation, hair removal, and vascular treatments. The system features improved precision, faster treatment times, and enhanced patient comfort.

✅ December 2025 - Lumenis (Israel / Global)
Lumenis introduced a next-generation laser and light-based dermatology platform for aesthetic and clinical applications. The device supports a wide range of skin treatments, including pigmentation, acne, and scar management.

✅ October 2025 - Cutera Inc. (United States)
Cutera released innovative dermatology devices integrating AI-assisted treatment planning and real-time skin assessment. The solutions help clinicians deliver personalized, consistent, and effective dermatological care.

✅ August 2025 - Alma Lasers (Israel)
Alma Lasers partnered with dermatology clinics and aesthetic centers to deploy multifunctional devices combining laser, radiofrequency, and ultrasound technologies. The collaboration focuses on expanding minimally invasive skin treatment options.

Mergers & Acquisitions
✅ January 2026 - Lumenis (United States)
Lumenis acquired a dermatology-focused energy-based device company to expand its portfolio in aesthetic and clinical dermatology. The acquisition strengthens capabilities in laser, RF, and IPL technologies for skin rejuvenation and medical treatments.

✅ December 2025 - Candela Medical (United States)
Candela Medical completed the acquisition of a non-invasive dermatology device manufacturer specializing in body contouring and skin tightening. The deal enhances Candela's offerings across aesthetic dermatology and cosmetic clinics.

✅ October 2025 - Cutera, Inc. (United States)
Cutera expanded its dermatology device portfolio through the acquisition of a digital dermatology and treatment-planning technology company. The acquisition reinforces Cutera's focus on precision, personalization, and advanced skin treatment solutions.

Segments Covered in the Dermatology Devices Market:
By Diagnostic Device
The market is segmented into Dermatoscopes 40%, Imaging Devices 30%, Microscopes & Biopsy Devices 20%, and Others 10%. Dermatoscopes dominate due to their widespread use in early detection of skin cancer and pigmented lesions, while advanced imaging devices are gaining traction for high-resolution skin analysis and digital dermatology.

By Treatment Device
Treatment devices include Laser Devices 35%, Light Therapy Devices (IPL & LED) 30%, Electrosurgical Devices 20%, and Others 15%. Laser devices lead due to high demand for aesthetic and therapeutic dermatology procedures, while light therapy devices are expanding rapidly for acne, psoriasis, and photorejuvenation treatments.

By Application
Applications include Aesthetic Dermatology 40%, Medical Dermatology 35%, Surgical Dermatology 15%, and Others 10%. Aesthetic dermatology dominates driven by rising demand for non-invasive cosmetic procedures, while medical dermatology remains strong for chronic skin conditions and skin cancer management.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=dermatology-devices-market?praveen

Regional Analysis
North America - 40% Share
North America leads with around 40% share, driven by high adoption of aesthetic procedures, strong dermatology infrastructure, and technological advancements. The U.S. dominates the market with widespread use of laser devices, energy-based systems, and diagnostic tools for skin rejuvenation, hair removal, acne treatment, and skin cancer detection.

Europe - 28% Share
Europe accounts for approximately 28% share, supported by growing demand for aesthetic and clinical dermatology treatments, aging population, and well-established healthcare systems. Germany, France, the UK, Italy, and Spain are key markets for dermatology lasers, light therapy devices, and diagnostic equipment.

Asia Pacific - 22% Share
Asia Pacific holds nearly 22% share due to rising awareness of skin health, expanding medical aesthetics industry, and increasing disposable income. China, Japan, South Korea, India, and Southeast Asia are driving demand for cosmetic dermatology devices, particularly for pigmentation, anti-aging, and hair treatments.

Latin America - 6% Share
Latin America represents about 6% share, fueled by growing medical tourism, aesthetic procedure demand, and improving healthcare infrastructure. Brazil and Mexico are leading markets for dermatology devices in cosmetic and clinical applications.

Middle East & Africa - 4% Share
Middle East & Africa holds around 4% share, with growth supported by increasing aesthetic awareness, medical tourism, and investments in dermatology clinics. GCC countries, South Africa, and Egypt are gradually adopting advanced dermatology devices.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?praveen

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.